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ABSTRACT
Su, Hengjie. M.S. The University of Memphis. May 2014. A Novel
Post-Electrospinning Treatment to Improve the Fibrous Structure of the Chitosan
Membrane. Major Professor: Dr. Joel D. Bumgardner.
Guided bone regeneration (GBR) membranes function as barriers in preventing
soft tissue migration into dental osteogenic spaces. Chitosan is a biocompatible and
degradable natural polysaccharide, which has shown potential in tissue regeneration
and GBR applications. Trifluoroacetic acid (TFA) is a common solvent used to make
the chitosan polymer solution for electrospinning process. However, the TFA salts
remaining in the electrospun nano-sized fibers induce the chitosan fiber swelling and
dissolution when placed in aqueous solutions leading to loss of nano-fiber structure.
The aim of this work was to evaluate an innovative method using triethylamine
(TEA)/ di-tert-butyl dicarbonate (tBoc) to treat the electrospun chitosan membrane
without losing nanofibrous structure or compromising compatibility. After the
treatment, the nanofibrous structure was well maintained in water overnight, which
was confirmed by the SEM. FTIR analyses confirmed TFA salt removal. Surgical
fixation tests indicated TEA/tBoc membranes have appropriate clinical handability.
The TEA/tBoc treated membrane also showed good cytocompatibility with
osteoblastic cells, as well as suitable degradation ration (23.7%) after 7 weeks.
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CHAPTER 1: INTRODUCTION
1.1 Current clinical problem
Guided bone regeneration (GBR) membranes are a critical biomaterial related
device in tissue engineering. They are widely employed in dental/maxillofacial
treatments combined with bone graft to regenerate the defect of cementum,
periodontal ligament, and alveolar bone due to chronic periodontitis, edentulism, or
traumatic injury.1 These membranes are used to direct the formation of bone in the
surgical sites and act as barriers to fast proliferating soft tissues to prevent their
migration into the bone graft site.2
Periodontitis is one of the most emphasized and researched dental condition
related to GBR membranes applications. Periodontitis is a prevalent disease occurring
globally and is characterized by periodontal tissue destruction, especially in bone loss
and further damage showed as tooth loss.3 It is reported that approximately one half of
adults older than 30 years have periodontitis in the United State.3 In 2006, over 5
million dental implants, valued over $150 million, were placed in the US due to
periodontitis, and number of implants placed per year is expected to increase due both
to the aging world population and the success of implant therapies.4 The goal of the
therapy for periodontitis is to reconstruct periodontal supporting structure in both
architecture and function as well as to prevent the further attachment and bone loss.5
Early in 1980s, experimental studies showed that placement of GBR membranes had
considerable positive effects on bone formation and these reported effects were much
better in comparison to no membrane placement in between the gingival tissue and
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the bone graft.5, 6 During the surgery, an occlusive GBR membrane is placed into the
defect site as a barrier to exclude the gingiva tissue migrating into the lesion, to
protect the regenerating bone tissues and graft materials and to prevent formation of
vertical deep crevices in between the mandible and the tooth (Fig. 1).5, 7, 8 Once
implanted the GBR membrane, typical healing response occurs in which cells located
in and around the surgical site adjacent to the tooth/bone tissues migrate in to the
protected space and the graft materials and grow and differentiate into new supporting
tissues including functional new bone, periodontal ligament and cementum.8 GBR
membranes are also employed for the restoration of reduced alveolar bone adjacent to
dental implants as shown in Figure 2.7, 8

Fig. 1. The GBR membrane is in the application of supporting structure repair. a.
vertical deep crevice in the mandible b. the GBR membrane is embedded in between
the mucosal flap and the debrided lesion c. the membrane start to degrade after 3-5
months d. reconstructed functional supporting structure.7
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Fig. 2. The GBR membrane is in the application of alveolar restoration. a.
defected alveolar b. after debriding the defect, the membrane and bone scaffold are
placed to help the tissue regeneration c. the membrane is shaped and stabilized to
descript the ideal alveolar contours d. months later, reestablished alveolar is
observed.7

1.2 Current GBR membranes
Current membranes in clinical application are classified as non-absorbable
membranes, such as polytetrafluoroethylene (ePTFE) membranes (e.g. Gore-Tex®),
and biodegradable membranes based on different synthetic degradable polymers such
as polyglactin membranes (e.g. Vicryl®), polyglycolic and polylactic acid (PGA/PLA
Copolymer) membranes (e.g. Resolut Adapt®) and biopolymer collagen-based
membranes (e.g. Biomesh® / Helisorb®).9, 10 The difference in these two types of GBR
membranes are the non-absorbable membranes require a second surgery for
removal.11 In contrast with non-absorbable membranes, absorbable membranes
degrade during the healing process, and thus do not need another surgical intervention
for removal.12, 13, 14 Therefore, absorbable membranes have become common because
of their benefit in clinical operation12, 13, 14. Compared with non-degradable ePTFE
membranes, collagen membranes have an enhanced ability support cell
proliferation.15 Although commercial collagen membranes are widely used clinically,
these bio-polymer membranes have been reported to be more easily contaminated by
3

bacteria, which leads to premature degradation, loss of barrier function and reduced
bone formation.16 For example, Paul et al. showed that when collagen membranes
became exposed, they became colonized by bacteria in the oral cavity, leading to the
early membrane degradation and can result in limited or no healing of the bone after 6
months.17 To overcome this shortcoming, antibiotics have been added in collagen
membranes.18, 19 According to a randomized clinical trial, a collagen membrane
saturated with metronidazole, a nitroimidazole antibiotic used to treat anaerobic
bacteria and parasitic infections, failed to have better infection resistance than the
collagen membrane without the antibiotic addition.18, 19 Though all commercial
membranes in the discussed clinical examples have made improvement in
periodontitis treatment, none of clinical studies have completely healed the
periodontal defects.14, 20, 21, 22 New materials need to be explored that provide space
protecting properties while also enabling growth and differentiation for cells
necessary for the regenerating tissues in order to improve GBR treatments in restoring
periodontal defects.
1.3 Requirements for GBR membranes
Ideally, to meet the clinical requirements, GBR membranes need to be nontoxic,
biocompatible, support cell proliferation, as well as have adequate mechanical
strength to act as a barrier between site for osteogenesis and the overlying gum
tissue.23 In addition, a study has reported that membranes that exhibit
nano-fiber/nano-porous structure are also advantageous to GBR membrane function.24
The nanoscale fiber structure mimics the native fibrillar structure of extracellular
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matrix to support cell attachments and growth and provides and additional advantage
of having increased surface area for adsorption of proteins and or drugs.23 The
nanofiber structure also results in porous structure for the communication between
osteoblastic and fibrous cells and nutrition exchange while remaining cell occlusive.25
Chitosan is a potential new material for GBR treatments. Chitosan is a
polysaccharide polymer that exhibits many of the characteristics, e.g. biocompatible,
non-toxic, bio-degradable, osteoconductive, and antimicrobial properties as well as
the ability to be formed into nanofibrous structures that are ideal GBR membrane
applications.24, 26 One of the most common ways to make nanofibrous chitosan
materials is by a process called electrospinning. Prior to reviewing use of chitosan and
chitosan nanofiber materials in GBR applications, a brief overview of electrospinning
process will be provided followed by an overview of the chitosan polymer.
1.4 Electrospinning
Electrospinning is a method used for producing fibrous structure with nano- to
micro- scale diameters.27, 28, 29 Electrospinning uses high voltage electrostatic forces to
spin a polymer solution into fibers that are collected to form fibrous membranes.
Although this technique was first introduced in 1914, it has not been used for making
tissue engineering scaffolds until recently by various research groups.23, 24, 25, 30 Basic
apparatus of electrospinning include a spinneret, a fiber collector and a high-voltage
power supply (Fig. 3).31 A spinneret is usually a needle tip connected to a syringe
containing a viscous polymer solution. The polymer solution is fed through the needle
tip at a steady slow flow rate under the control of a syringe pump.31 A fiber collector
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is placed facing the spinneret a certain distance away and may be rotated to collect the
fibers. In the consideration of the membrane application, various shape and forms of
collector have been invented to produce membranes with required designs such as
tubes, meshes, microbundles, and plain mats.32 A power supply provides high
voltage/low current to create an electrostatic field between the spinneret and the
grounded metallic collector during the electrospinning process. During spinning
process, the polymer solution forms a pendent droplet at the needle tip under the
voltage gradient is elongated into a conical shape by the electrostatic repulsive
force.33 The conical shape is also well known as Taylor cone.33 Once the electrostatic
force exceeds the surface tension of the polymer droplet, a charged jet is forced from
the tip of the Taylor cone and then is stretched and whipped to the collector in a series
of nano fibers.33 Generally, the fiber size is highly influenced by the applied voltage,
polymer solution viscosity, distance between the fiber collector and the spinet,
solution pumping rate, and even the room humidity.24
1.5 Chitosan
Chitosan is derived from chitin, a polysaccharide that is widely distributed in
crustacean shells. The chitin polymer is composed predominantly of N-acetyl
glucosamines and the polymer is insoluble in aqueous solutions.26 Treating chitin with
strong base removes the acetyl groups resulting in a co-polymer of N-acetyl
glucosamine and glucosamine. When more than 50% of the repeat units in the
polysaccharide are glucosamine, the polymer is called ‘chitosan’. The mole fraction of
glucosamines in the polymer is referred to as the degree of de-acetylation, DDA and
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may range for 50% to 100% DDA (or 100% glucosamine repeat units). Since this
biopolymer belongs to the alkali polysaccharide family, chitosan has bacteriostatic
power.34, 35 It has been demonstrated that two oral pathogens, actinobacillus
actinomycetemcomitans and stretococcus mutans, were inhibited at a chitosan (91.5%
DDA) concentration as low as 0.001% in an in vitro study.34, 35 Additionally, chitosan
is easily processed into membranes, nanofibers, nanoparticles, and sponges.24, 36, 37

High Voltage
Syringe

Power Source
Spinneret

Pump

Syringe
Collector

Fig. 3 Electrospinning apparatus in BAM laboratory

1.6 Chitosan GBR membranes
Chitosan has shown great potential in the GBR application. In a recent review
article by Xu et al., several resorbable membranes of chitosan, polylactic acid,
polyglycolic acid and lactide/glycolide copolymer that had been used in animal
studies were compared.34 It was noted that the chitosan membranes helped to generate
more volume of cementum and bone cells, and more regular arranged cementoblasts
7

and osteoblasts along the new bone surface than either the polylactic acid,
polyglycolic acid and lactide/glycolide copolymer membranes.34
By combining chitosan and electrospinning, electrospun chitosan membranes
have obvious combined advantages in GBR treatment. Electrospun chitosan
membranes have shown improved cell compatibility in vitro and in vivo and have
great potential for drug loading.38, 39, 40, 41 Shin et al. produced electrospun chitosan
membranes and showed that the membranes had cyto-compatibility with hepatic cells
in vitro, and was potentially viable for use in tissue formation.38 Norowski et al.
produced a series of genipin crosslinked membrane and showed cyto-compatibility
with osteoblast cells and biocompatibility and effective functional degradation ratio in
vivo study.39, 40 Sangsanoh et al. compared schwannoma cell growth on several kinds
membranes, demonstrating the cyto-compatibility of electrospun chitosan membranes,
as well as prior than poly(3-hydroxybutyrate) and poly(3-hydroxybutyrate-co-3hydroxyvalerate) electrospun fibers.41 However, while these studies have highlighted
some potential advantages of the chitosan electrospun membranes for GBR, the
clinical handibility of membranes has not been optimized.42 This limitation is largely
attributed to the limited number of solvents used for making the chitosan
electropinning solutions in order to have enough surface tension for electrospinning.
1.7 The current problem of electrospun chitosan membranes
Commonly, trifluoroacetic acid is the primary solvent for preparing the chitosan
solution used for electrospinning chitosan membranes. Through research from Geng
et al., their study reported using concentrated acetic acid as the main solvent for
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successfully electrospinning chitosan into membranes.43 This work has not been
replicated since it is difficult to get the chitosan dissolved in acetic acid to have
enough surface tension strength and viscosity for the electrospinning process.44 On the
other hand, chitosan dissolved in trifluoroacetic acid has the elastic and viscous
properties for easily being stretched into fibers that is required for electrospinning.45
Chitosan membranes made from trifluoroacetic acid need a post electrospinning
chemical treatment to neutralize/remove the residual strong acid in the membranes.
However, the trifluoroacetic acid salts (TFA salts) generated from the solvent in
chitosan membrane are extremely hydrophilic and can easily induce the swelling and
dissolution of the membrane fibers. The most widely used methods for the
neutralization of electrospun chitosan membranes is by soaking in highly saturated
NaOH or Na2CO3 solution. Sangsanoh et al. has explained the possible neutralization
principle with highly saturated NaOH or Na2CO3 solution and then demonstrated that
the 5 M Na2CO3 solution is more effective in keeping the fibrous structure of the
chitosan membrane than the 5 M NaOH solution.46 In their theory, excess Na2CO3 in
the saturated solution drives the continuous neutralization reaction toward the result
of trifluoroacetic acid elimination, hence to exclude the swelling. They also indicted
that the H2O molecules generated from NaOH neutralization process may be the
reason for the swelling of the chitosan membrane. This theory is on the basis that the
neutralization reaction happens quickly and the rapid rate may shield the effect of the
water solvent. The assumption being that by avoiding the H2O molecules generated
from the neutralization process it would be possible to avoid membrane swelling. In
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reality evaluation though, the fibers still swell leading to loss of the nano fiber and
structure. Other studies have tried to stabilize the fibers by crosslinking agents but success in
maintaining the fiber structure has been limited.47, 48, 49, 50
1.8 Aim
In this investigation work, an innovative post electrospinning chemical treatment
was evaluated for removing residual TFA salts and for maintaining the nano-fibrous
structure. This treatment is focused on eliminating TFA salts and not just neutralizing
the pH value from acid to mild neutral. Additionally, since amino groups in the
chitosan are also likely to contribute to fiber swelling and loss of nano-fibrous
structure. To minimize fiber swelling, triethylamine (TEA) in acetone will be used as the
agent for dissolving the TFA salts since the salts are easily dissolved in the TEA/acetone
solution but will not cause swelling of the fibers (Fig. 4). In addition, di-tert-butyl
dicarbonate (tBoc) will be used to generate hydrophobic wrap around amino groups of
the chitosan molecule. By blocking the amino groups, the hydrophilic character of the
fibers will be reduced thereby further reducing/minimizing swelling of the chitosan
nanofibers in the membrane.
The objective of this project is to compare and evaluate the new-post-processed
electrospun membranes by electron microscope for nano fiber structure as compared to
typical base neutralized membranes. Cell compatibility and degradation of the
new-post-processed electrospun membranes will be tested in vitro. Additionally, a simulated
surgical fixation test will be use used to assess the mechanical strength and handability of the
new post-processed chitosan membrane and effects of increasing membrane thickness.
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CHAPTER 2: A NOVEL POST-ELECTROSPINNING TREATMENT TO
IMPROVE THE FIBROUS STRUCTURE OF THE CHITOSAN MEMBRANE
ABSTRACT
Guided bone regeneration (GBR) membranes are employed in the bone generation of
the periodontal tissues lost to injury or disease, and function as barriers between soft
gingival tissues and bone regenerating space. Chitosan has been investigated as a GBR
material due to its biocompatibility, degradability, and the ability to electrospun chitosan
membranes with nanofibrous structure. However, residual acid salts from the
electrospinning process make the as-spun material highly susceptible to swelling,
dissolution, and loss of nano-fiber structure. This study investigated the use of a novel
process to retain the nanofiber during removal of the acidic salts. Membranes were made
by electrospinning 5.5wt% 71% degree of deacetylation (DDA) chitosan from a 70%
trifluoroacetic aced (TFA) - 30% dichloromethane (DCM) solution at 26 kV. The
membranes were first washed in triethylamine (TEA)/acetone to remove the TFA salts
and then treated with di-tert-butyl dicarbonate (tBoc) to wrap the amino group to
hydrophobic. Electron microscopy analyses showed that that fibers had 330 ±130μm
diameter and retained nanofibrous structure after immersion in distilled water overnight.
FTIR confirmed the removal of the TFA salts. Membranes exhibited ability to support cell
growth for at least 5 days and to degrade 23.7% after 7 weeks in vitro. A simulated
surgical fixation test indicated that the TEA/tBoc treated chitosan membranes exhibited
mechanical properties within range of current clinically used membranes.
Keywords – Chitosan, Electrospinning, nanofibrous structure
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INTRODUCTION
Guided bone regeneration (GBR) membranes are widely applied in the formation
of the new bone in periodontitis treatments.1 Periodontal regeneration aims to reform
the epithelial seal, acellular extrinsic fiber cementum, as well as to restore the alveolar
bone height.1 Because of the faster growth rate of gingival connective tissue, GBR
membranes are placed in between the soft tissue and regenerating bone to prevent the
gingival connective tissue from intruding into the alveolar bone site.2
In general, GBR membranes should have the characteristics to promote cellular
functions, such as biocompatibility, biodegradability, non-toxicity, high porousity,
interconnected pores in nano-size range in order to be cell occlusive, large surface
area-volume ratio, and adequate mechanical strength.3 One of used ways to make the
GBR membrane is electrospinning, which applies a high voltage to the polymer
solution to spin the material into fibers. Chitosan is a natural polysaccharide used in
electrospinning the GBR nano-fiber membranes because it is biocompatible,
biodegradable, non-toxic and has been widely used in tissue scaffolds.4, 5, 6, 7
Past studies have shown that chitosan nano-fiber membranes may be made via
electrospinning processes.2, 4 These membranes in general have exhibited adequate
biodegradation rates and good biocompatibility,2, 4, 8 though tear strengths of the
membranes were 51% - 67% lower than that of commercially available collagen
membranes.8 Additionally, residual acidic salts from the electrospinning process make
the nanofibers highly susceptible to swelling and dissolution. Trifluoroacetic acid
(TFA) is widely used as the solvent for making the electrospinning chitosan solution
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since it provides better viscosity property than other solvents such as acetic acid.5, 9
TFA salts are generated with the chitosan polymer during the electrospinning process
and these salts make the chitosan fibers extremely hydrophilic, and easily induce
swelling and dissolution in aqueous solution. In the previous studies, saturated
Na2CO3 and NaOH solutions have been employed as methods to neutralize and
remove the TFA salts.10 Furthermore, several crosslinkers such as glutaraldehyde and
genipin have also been used in order to try and stabilize the membranes in water
condition.11, 12, 13, 14 However the success of the Na2CO3 and NaOH treatment and
crosslinking strategies to stabilize fibers and prevent swelling have met with limited
success and from our experience, were inconsistent in preventing fiber swelling and
hard to reproduce.
The goal of this research was to improve the nanofiber structure of the electrospun
chitosan membranes and their mechanical properties. In order to improve and maintain
nano-fibrous structure of the electrospun membranes, a new post electrospinning
chemical treatment was evaluated. The new treatment used triethylamine (TEA) in an
acetone solution coupled with a blocking of the chitosan amino groups by di-tert-butyl
dicarbonate (tBoc) in a tetrahydrofuran (THF) solution. The TEA/acetone solution is used
to remove residual acid salts from the spun membranes and the tBoc is used to prevent
swelling of the fibers to maintain the nano-fibrous and nano-porous structure of the
membranes. In addition, membrane thickness was increased in this research in order to
increase the general mechanical strength. Electrospun membranes treated by 5 M
Na2CO3 solution, were used as the control group.
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Fiber morphology of the TEA/tBoc and carbonate treated membranes was
measured by SEM and chemical/crystal structure evaluated by FTIR and XRD.
Mechanical strength of the membranes based on surgical fixation tearing strength and
degradation of the membranes were measured. In addition, the attachment/growth of
cultured cells to the membranes over 5 days was also done to evaluate the
biocompatibility.
MATERIALS AND METHODS
Electrospinning
Electrospinning of the chitosan membranes was based on the method previously
reported by our group.4, 8 Before the electrospinning, chitosan solution was prepared by
gently mixing 5.50% (w/v) chitosan in 70% (v/v) trifluoroacetic acid and 30% (v/v)
methylene chloride overnight. A 10 mL syringe with a 20 gauge, 3.81 cm blunt needle was
used to load the solution. The rate of the syringe pump was set to 15 μL/min. Then the
syringe was placed into the syringe pump. A 26kV voltage was connected between the
needle tip and collection plate for electrospinning the solution into nanofibers. The needle
tip was positioned a distance of 15 cm, from the collection plate. The collection plate was
covered by nonstick aluminum foil and the fibers collected on the surface while rotating the
plate at speed of 8.4 rpm to ensure random orientation. To increase the thickness of the
membranes, three 10 ml volumes of the chitosan spinning solution were spun consecutively
to produce an un-neutralized membrane approximately 0.7 ±0.1 mm thickness and
approximately 15 cm in diameter. The electrospinning process was shielded by ventilated
plastic glass box and operated under the room temperature and 50% - 60% moisture.
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Post-electrospinning treatment
Non-neutralized chitosan membranes was immersed in 10% (v/v) TEA/Acetone
solution for 24 hours under mild magnetic stirring to completely remove all
trifluoroacetate ions and rinsed in pure acetone for 2 hours. The rinsing procedure was
repeated 2 times in order to remove excess TEA. The salt free chitosan membranes
were then soaked in an acetone solution containing 2 g tBoc for 48 hours under mild
magnetic stirring at 65°C. Membranes were rinsed by acetone for 2 hours and
repeated 2 times to fully remove unreacted tBoc and dried in between two pieces of
nylon net in air.
For the control group, electrospun membranes were treated by saturated Na2CO3
solution. Chitosan membranes were soaked in 5M Na2CO3 solution for 3 hours. Then
the Na2CO3 solution was rinsed off by distilled (DI) water. To make sure that all the
Na2CO3 solution was washed off, the rinsing process was repeated 3 to 4 times. Then
the chitosan membranes were placed in-between two pieces of nylon net for drying in air.
Scanning electron microscopy (SEM)
The morphology of the fibers in the electrospun membranes was examined by
scanning electron microscopy, SEM (EVO HD15, produced by Carl Zeiss AG).
Disc-shaped specimens (~1cm diameter) of the chitosan membranes were attached to
an SEM stub and coated with 8 nm gold-palladium. Three samples of each membrane
from three different electrospun membranes were examined from 2500X to 6500X. In
each sample, more than 20 fiber diameters were recorded.
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Fourier Transform Infrared Spectroscopy (FTIR)
To evaluate the extent of trifluoroacetic acid salt elimination, FTIR spectra were
collected using a Nicolet 380 FTIR spectrometer (Thermo Electron Corporation).
Spectra were collected for the chitosan starting powder, non-neutralized and
neutralized chitosan membrane specimens. Four samples of each membrane were
scanned from 500 cm-1 to 4000 cm-1 for 32 times.
X-ray Diffraction (XRD)
XRD was used to examine the crystallinity of the chitosan in the membrane fibers.
Membranes neutralized by TEA/tBoc were first grounded into fine powders after
immersing in liquid nitrogen by a mortar and pestle. Grazing angle reflection mode
was the scanning mode. Data was collected from 2Θ = 4 to 30. Chitosan powders,
non-treated membranes, Na2CO3 treated membranes, and TEA/tBoc treated
membranes were examined (n = 4).
Contact angle measurement
Water contact angle measurements were used to measure the hydrophobic
characteristics of the TEA/tBoc treated membranes and carbonate treated membranes.
Contact angle of the water drop contacting the membrane surface was observed by
VCA optima measurement machine (produced by AST products, INC) and the result
was recorded. Four samples of each Na2CO3 treated and TEA/tBoc treated
membranes were used.
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In vitro cell viability and proliferation
Ethylene oxide gas sterilized disc-shaped chitosan membrane
specimens (diameter = 1cm) were inserted in 24 well-plates for evaluating the growth
of osteoblastic cells on the membranes over 5 days. Each plate contained both the
experimental and control membranes. The membranes were fixed to the well bottom
by round silicone rings, cut from silicone tubing. The rings had an inner diameter
of 6 ±2 mm. Membranes were rinsed in culture media three times, and then were
seeded with Saos-2 human osteoblastic cells (Cat. No. HTB-85, ATCC, Manassas, VA,
USA) at 1.5×105 cells/well (105 cells/mL × 1.5 mL media/well). Cells were grown in
McCoy’s 5a medium (Modified) mixed with 10% FBS and 500 I.U. /mL
penicillin, 500 μg/mL streptomycin, and 25 μg/mL amphotericin-B. Cell growth was
measured using the Cell Titer GloTM luminescent cell viability assay (Promega,
Madison, WI, USA). The assay was based on luciferin-luciferase reaction to measure
the amount of oxidation of ATP, which is proportional to the amount of
cells (n=4/sample per day). Data was reported in relative fluorescent units and
compared in between the groups of TEA/tBoc treated membranes and Na2CO3 treated
memrbanes. Cell viability and morphology were qualitatively observed by fluorescent
microscopy using Live-Dead®stain (Molecular Probes, Eugene OR, USA).
Surgical fixation test
Since GBR membranes are generally secured to adjacent bone tissues using small
tacks or screws,14, 15 a surgical fixation test was used to evaluate the mechanical
properties of the TEA/tBoc treated membrane, as an indicator of clinical handability.
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In this test, white oak wood was used as a bone analogue for tearing the membrane.16
Using a mechanical test frame, the tensile force necessary to tear/break the membrane
from the tack was measured before mechanical testing, each type of membranes was
prepared to be the same size, 10×40 mm2 squares.
In the surgical fixation test, the 10×40 mm2 square sample was tacked to a piece
of 7.5×7.5×0.5 cm3 white oak as a bone analogue by a medical tack (AutoTac system
kit, Biohorizons) at the position of 5 mm from the bottom edge and each sides. The
wood with the sample was positioned in the lower clamp of the InstronTM model 4456
mechanical test frame, and the free end of the membrane was positioned in the upper
clamp (Fig. 1). The load cell used was 50 N and the extension rate was 1mm/min.
Maximum load was recorded in Newton (N). After soaking in phosphate buffered
saline (PBS) for 1 hour, membranes were tested in wet condition following the same
procedures. In each surgical fixation test, three samples of each membranes were tested.
Degradation
The degradation of membranes (based on mass loss) was evaluated in PBS
solution at 37 ˚C. Membranes were prepared into 3 cm2 squares and soaked in the
PBS solution containing 100 μg/mL lysozyme, 500 I.U./mL penicillin, 500 μg/mL
streptomycin, and 25 μg/mL amphotericin-B. At 1, 3, 5 and 7 week time points in
PBS-lysozyme solution, membranes were retrieved, rinsed in DI water, dried for 48
hours at 60 °C and then weighed (g) to record the change in mass. Membranes were
then returned to the PBS-lysozyme solution and incubation time periods resumed.
Although lysozyme in human physiology condition is not as high 100 μg/mL, this
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high level was used to accelerate degradation and magnify potential differences over
the course of the experiment. Mass fraction residue was used to show the result in
grams.
Statistical analysis
ANOVA at the 0.05 level of significance was used in the statistical analysis of
fiber diameters (n = 3/membrane), degradation (n = 4/membrane), contact angle (n =
four/membrane) and mechanical (n = 3/membrane) tests.
In cell proliferation test, two-way Analysis of variance (ANOVA) was used to
analyze the cell proliferation data using type of membrane (n=4/membrane) as one
factor and time as the second. As appropriate, Tukey’s post-hoc tests were used to
distinguish significantly different groups.
RESULTS
SEM
The membrane maintained the nano-fibrous structure after the TEA/tBoc treatment
(Fig. 2 A). Fiber diameters were in the nano-scale. Though the fibers were fused and
dissolved to some extent after soaking in DI water 12 hours, the membrane still kept the
porous structure with fiber diameters remaining in the nano-scale size range (Fig. 2 B).
The fiber diameters are 330±130 μm before contacting water and are 530±320 μm after
soaking in water. In comparison, the membrane lost all the fibrous structure after the
Na2CO3 treatment (Fig. 2 C). It is also noted that membranes only with the TEA treatment
exhibited excess swelling or dissolution after twelve hours in water (Fig. 2 D), indicating
that the stability of the membranes is due to the tBoc on the chitosan amino groups.
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FTIR
The FTIR spectrum reveals the changes in the membrane during the TEA/tBoc treatment.
After the TEA treatment, three transmittance peaks related to TFA salts at 720, 796 and 836
cm-1 in the spectrum should be eliminated after TEA treatment. FTIR spectra revealed that the
three transmittance peaks related to TFA salts at 720, 796 and 836 cm-1 disappeared after the
TEA/tBoc treatment (Fig. 3). After the tBoc treatment, CO-NH group expressed as the peak
at 1527 cm-1 and tBoc group expressed as the peaks at 1366.7 cm-1 and 1392.8 cm-1 in the
spectrum has appeared, as well as the peak of C=O group at 1688 cm-1 has increased.
XRD
Crystallinity of chitosan was mainly determined by the peak intensity differences
at 2Θ = 20 and the lowest point of the baseline (amorphous region) at 2Θ = 12
normalized to the peak intensity in XRD. Although the spectra of the chitosan powder
exhibited both peaks at 2Θ = 12 and 2Θ = 20, all electrospun chitosan membranes had
lost the peak at 2Θ = 20. These results suggested that the chitosan had less
crystallinity structure after being electrospun into the membrane (Fig. 4).
Contact Angle measurement
Results of the water contact angle test are shown in Figure 5. The contact angle of
the water drop on the TEA/tBoc treated membrane surface was 119.4 ±14 degrees
(Fig. 5 A). The contact angle of the Na2CO3 treated membrane was 95.9 ±10.8
degrees (Fig. 5 B), which is significantly less than the contact angle result of
TEA/tBoc treated membranes (p = 6.74×10-5).
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In vitro cell viability and proliferation
Results of the cell growth on the TEA/tBoc treated and the Na2CO3 treated
membranes are shown in Figure 6 and 7. Viability staining revealed high cellular
viability of osteoblasts for both membrane types (Fig 6). Cell proliferation, based on
cellular ATP levels, indicated a statistically lower number of cells on day 1 and day 3
for the TEA/tBoc treated membrane as compared to the Na2CO3 treated
membranes (p = 10-6 at day 1 and p = 4.17×10-5 at day 3) (Fig. 7). However, there was
no statistical difference in the number of cells between the two membranes types at
day 5 based on relative luminescence units (p = 0.13).
Surgical fixation test
In the surgical fixation test, the maximum loads normalized to the thickness are
shown in Figure 8 A. The average tearing strength of the TEA/tBoc treated
membranes was 62.1 N/mm (±1.87 N/mm) in dry condition and 28.0 N/mm (±0.44
N/mm) in wet condition. Averaging the tearing strength of dry and wet condition, the
average tearing strength of TEA/tBoc treated membranes was 45.1 N/mm (±1.02
N/mm). The tearing strength of commercial collagen BioGuide membrane was 133.9
N/mm (±21.5 N/mm) in dry condition, and 124.5 N/mm (±8.61N/mm) in wet
condition. The tearing strength of the PLA GUIDOR membrane was 34.9 N/mm in
dry condition, and was 22.2 N/mm in wet condition. The tearing patterns of the
membranes were shown in Figure 8. According to the ANOVA analysis, the tearing
strength of TEA/tBoc membranes was significantly less than that of BioGuide collage
membranes in dry (p = 0.0045) and wet (p = 0.0079) condition. There was no
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significant difference in between the dry and wet condition of BioGuide collagen
membrane (p = 0.63), but there were significant differences between the dry and wet
condition of TEA/tBoc treated membranes (p = 1.63×10-4).
Degradation
The degradation experiment showed that the TEA/tBoc treated membranes
decreased in weight in a similar pattern to the Na2CO3 treated membrane during the 7
weeks (Fig. 9). There were no statistical differences (p = 0.21) between the decreased
weights of the both groups at each week point.
DISCUSSION
The objective of this work was to evaluate a novel post-spinning treatment to
remove acidic acid salts and retain nano-fiber structure of electrospun chitosan
membranes. This work also evaluated increasing the thickness of the membranes to
improve their handablity and mechanical properties.
We used three 10 mL volumes of chitosan solution to electospun sequentially to
make thicker membranes as compared to membranes made by our group previously.4
These thicker membranes may have been produced by electrospinning a single 30 mL
chitosan solution directly. However the electrospinning process of chitosan requires
close monitoring to ensure constant spinning process and the larger volumes would
have required an undue extended time for monitoring the spinning process. While
sequential spinning to build up the membrane in layers added time to the overall
process, ability to monitor the spinning process in shorter time intervals was an
advantage. Additionally, SEM examination of torn edges of the TEA/tBoc treated
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membranes spun from sequential solutions did not exhibit any layering effect and the
fibers were of similar nanometer diameter size (data not shown). This observation
indicated that electrospinning a thicker membrane using three sequential solutions did
not result in distinct layers and nor altered inner fibrous structure of the membrane.
The post treatment process used TEA to remove the TFA salts, followed by tBoc
to wrap the amino group. Since chitosan is not dissolved in organic solutions, all the
treatments were undertaken in the organic solvents (acetone/THF) to prevent swelling
by water. TFA salts in electrospun chitosan membranes may be removed by a strong
base. TEA was chosen as a base to remove the TFA salts because the TEA has a pKa
around 11, which is greater than the amino groups of chitosan (pKa ~ 6.5) and thus
will form stronger salt with the TFA than the chitosan. Since the TEA-TFA salts are
soluble in acetone, the TFA will be leached out of the chitosan and bound to the TEA
and then rinsed off in the acetone solution. After removing the TFA, the free amines
of the chitosan were protected by the tBoc reaction to reduce the overall free-amino
groups and to reduce the overall hydrophilicity of the chitosan polymer. The protected
amino groups of TEA/tBoc treated chitosan membranes are stable in neutral or basic
condition, but not in strong acid condition thus providing protection for the fibers
from swelling in water.
SEM examination of the membranes demonstrated that the TEA/tBoc process
succeeded in retaining the nanofibrous structure, especially compared with the
traditional Na2CO3 treatment. FTIR analyses showed that the TFA salts were removed,
and in vitro cell culture and degradation tests demonstrated that the TEA/tBoc treated
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membranes were cytocompatible and degradable. These results strongly suggest that
the TEA/tBoc treatment may be an effective means for retaining nanofibrous structure
of chitosan electrospun membranes for GBR applications.
SEM examination of the fiber structure of the TEA/tBoc and Na2CO3 treated
membranes showed that the TEA/tBoc treated membranes retained nanofibrous
structure after treatment and even after soaking in aqueous solution overnight,
whereas the Na2CO3 treated membranes exhibited much deterioration of the nanofiber
structure. Some swelling and fusion of the fibers of the TEA/tBoc treatment materials
occurred after soaking water overnight, but the diameters of the fibers remained in the
nano-scale range. Since that the fiber diameters of extra cellular matrix are
from 80 to 500 nm, and thinner fibers have been linked to increased biocompatibility
of a material,17 the fibrous structure we achieved was consistent with mimicking the
extracellular matrix and holds promise for improving barrier membrane properties.
Our results contrast with the results from Norowski et al., in which genipin in
conjuction with Na2CO3 was used to try and stabilize the fibers, but with only limited
success.4 In Volpato’s work, NH4OH was used to neutralize the TFA salts, the fiber
diameter increased to 1 μm after the treatment.17 Austero, tried to use several
crosslinkers (genipin, hexamethylene-1,6-diaminocarboxysulphonate and
epichlorohydrin) to increase the water stability but the membranes still lost most
fibrous structure after the basic treatment.18

Since the hydrolysis of the TFA salts are considered the reason for membrane
swelling and water dissolution, TEA treatment was used to remove all the TFA salts in
25

the chitosan membrane. The FTIR result has shown that all the peaks related to the
TFA salts, which were at 720, 796 and 836 cm-1 in the spectrum, have completely
gone after the TEA treatment, indicating that all the TFA salts were eliminated after
the treatment. However, chitosan membranes at this stage still lost most of the fibrous
structure after contacting water for overnight. The amino groups were then regarded
as leading to the swelling and dissolution since the amino group is extremely
hydrophilic. It was expected that the amine group would be protected by the tBoc
treatment. The peaks around 1600 cm-1 showed an increased height after the tBoc
treatment in the spectrum. These peaks indicated the presence of the tBoc molecule,
which was also confirmed by the increase in water contact angle and hydrophocitiy
characteristics. Since tBoc contains large butyl groups which are hydrophobic, their
presence on the chitosan fibers would result in an increased water contact angle and a
more hydrophobic surface. The retention of the nanofiber structure observed in the
SEM is attributed in large part to the tBoc wrap and increase in hydrophobic
characteristics. Chen et al., have depicted the disappeared three peaks related TFA
salts after the TFA salts were totally removed.19 Ju et al. have proved the existence of
tBoc wrap by the peaks at the similar position with ours in their work.20
The diffractograms of XRD result showed that there was less crystallinity after
making the chitosan powder into the electrospun membranes. The untreated
electrospun membrane lost the peak at 2Θ=20, and the same to the treated membranes,
which showed that the both TEA/tBoc and Na2CO3 treatments did not influence the
crystallinity of the chitosan. Decreased crystallinity is associated with more open
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molecular structure, which resulted to increased degradation, less resistance to
swelling and reduced tearing strength. Compared with the diffractograms of the
electrospun chitosan membrane from Zhou, we have similar patterns with theirs.18
Zhang also reported a similar XRD pattern, the peak in the diffractogram of chitosan
powder at 2Θ=20 was lost after electrospinning.21 In both studies, water swelling
problem was observed.18, 21
Clinically, surgical tacks are one common method to secure the membrane on the
bone during treatment.22, 23 Surgical tack test provides a means to simulate the how
the membrane will be handled and used in clinical operation. The tearing strength of
the TEA/tBoc treated membrane with increased thickness was 55.3% less than the
tearing strength of the commercial collagen Bio-Guide membrane in dry condition,
and was 77.5% less than the tearing strength of the commercial collagen Bio-Guide
membrane in wet condition. The tearing strength of the PLA GUIDOR membrane
was 43.8% less than the tearing strength of the TEA/tBoc treated membrane with
increased thickness in dry condition and was 20.7% less than the tearing strength of
the TEA/tBoc treated membrane in wet condition. The tearing strength of the
TEA/tBoc treated membrane in dry condition was significantly more than that after
soaking in PBS for 1 hour. According to the fact that swelling decreased the fiber
strength, this result was consistent with the SEM result that the membrane fibers swell
after soaking in water. Though the tearing strength of TEA/tBoc treated membranes
was significantly lower than the BioGuide collagen membranes in both dry and wet
condition, it was similar to the result of GUIDOR PLA membranes. Hence, the tearing
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strength of TEA/tBoc treated membranes was in the range of clinical requirement,
suggesting that the membrane was able to be stabilized on bone by tacks and function
as a secure cover. By examining the torn patterns of the membranes, the BioGuide
collagen membrane presented extremely elasticity during the tearing process (Fig. 8 C).
TEA/tBoc treated membranes had the similar torn patterns with the collagen
membranes but lower elasticity (Fig. 8 B), as well as the GUIDOR PLA membrane
was torn in the middle part of the membrane instead of the tearing edge (Fig. 8 D).
The torn patterns relate to the clinical handability. With the similar tearing strength,
TEA/tBoc treated membranes with increased thickness could be easier fixed in the
wound and keep better coverage function than the GUIDOR PLA membranes. The
tearing strength of Na2CO3 treated chitosan membrane electrospun by 10 mL chitosan
solution from Norowski et al. was less than 10 N/mm.8 However, they get this data
from the suture test instead of the surgical fixation test. In order to make the
comparison, we tested the tearing strength of the chitosan membranes electrospun
by 30 mL solution (treated by the both TEA/tBoc and Na2CO3 methods), shown 5 to 7
times more than the tearing strength of the Na2CO3 treated chitosan membrane
electrospun by 10 mL chitosan solution (data not shown).
Five days osteoblast growing study evaluated the cell compatibility of the GBR
membranes (Fig. 6). The TEA/tBoc treated membrane showed less osteoblast
proliferation than the Na2CO3 treated membrane at day 1 and day 3, but was not
different at day 5. Although it is not clear why this happened, since the TEA/tBoc
treated membranes are hydrophobic at least initially, the lower growth of cells at
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day 1 and 3 may reflect a lower number and, or slower rate of cell attachment to the
membranes as compared to the carbonate treatment membranes. The swelling of the
fibers in water overnight may suggest that they become less hydrophobic. Cells grow
better on hydrophilic surface than hydrophobic surface. Hence after a brief period of
time, the cells were able to attach well to the tBoc treated membranes and proliferate
normally so that there was no difference between membranes by day 5. The high
viability and normal morphology were confirmed visually via the live/dead
stain (Fig. 7).
The degradation study did not show that the TEA/tBoc treatment had significant
influence on the degradation rates compared with the Na2CO3 treatment. At the end of
seven weeks, the TEA/tBoc treated membranes lost 23.9% of the original weight, as well as
the Na2CO3 treated membranes lost 43.4%. From earlier work of our group, one layer
Na2CO3 treated membranes lasted 16-20 weeks in vivo until showing significant
degradation.7 Since TEA/tBoc treated membranes showed similar behavior, it is expected
that the degradation profile of the TEA/tBoc treated membrane would be able to meet the
target of 4-6 month healing time frame as an effective barrier function.
CONCLUSION
A new post-electrospinning treatment to the chitosan membrane was assessed in
this research, which has successfully preserved the porous structure in the 8 hours DI
water environment with good cell compatibility and degradation rate. Also, the tearing
strength of the chitosan membrane was significantly improved compared with the
previous study.8
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FIGURES

Fig. 1 The setup of surgical fixation test. Load cell: 50N. Extension rate: 1mm/min
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A

B
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D

Fig. 2 SEM graphs of chitosan membrane treated by A. TEA/tBoc, 6000X, B.
TEA/tBoc after soaking in water overnight, 6500X, C. 5M Na2CO3, 6500X and D.
TEA after soaking in water overnight, 6500X.
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Fig. 3 The FTIR spectra of the TEA/Boc treated membrane in different treatment
procedures, non-treated chitosan membrane, membrane after removal of TFA (TEA
treatment), and membrane with tBoc protection (tBoc treatment). The transmittance
peaks related to TFA salts at 720, 796 and 836 cm-1 disappeared after the TEA/tBoc
treatment. The increased peak at 1500 cm-1 indicated more hydrophobic after tBoc
treatment.
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Fig. 4 The XRD of chitosan powder, non-treated, 5M Na2CO3 treated and TEA treated
chitosan membranes.
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Fig. 5 Graphs of the water contact angle on the surface of the A. TEA/tBoc treated
membranes and B. Na2CO3 treated membrane.
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Fig. 6 Live/Dead graphs (A. chitosan membrane treated by TEA/tBoc, B. chitosan
membrane treated by Na2CO3) of the cell viability observed at 40X. Green dots were
live cells, and red dots were dead cells.
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CHAPTER 3: FUTURE STUDIES
This study needs further examination in the future. The time frame of TEA/tBoc
treated membranes losing their fibrous structure is still unknown and should be
investigated. The fibrous structure of membranes soaked in PBS for 1, 2, 3, 5, 7, 14,
and 21 days should be observed under the SEM. Degradation tests in this study applied
vacuum oven at 60 °C to dry the samples. It is not clear whether this 60 °C would affect the
chitosan degradation. Hence, another method used to evaluate the degradation ratio
should be used as verification.
Other than considering the cyto-compatibility, the investigation of oral bacterial
reacting with TEA/tBoc membrane will be needed. By increasing the hydrophobic
properties of the nanofibers, the ability of the bacteria to attach and grow may be
reduced and thereby provide an additional advantage for reducing infectious
complications of GBR membranes.
The fixation test showed that our membranes had significantly lower tearing
strength than BioGuide collagen membrane. Ways to improve the tearing strength
may still be needed. Ways to improve the mechanical properties may be by adding
crosslinkers or calcium phosphate mineral.42 TEA/tBoc membranes showed adequate
cell compatibility in vitro, though it is necessary to know whether they will perform
well in vivo. Animal study of small animals (rats) and larger animals (dogs) will be
required to test the biocompatibility in vivo in addition to in vitro compatibility results.
Calvaria defect models could be used in the rat model to evaluate biocompatibility
and inflammation response. The functional use as a GBR membrane in periodontal
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defect could be studied using a canine model. In addition, loading anti-inflammation
and antibiotic drugs to membranes may also be used to improve trauma healing and
prevent infection.
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CHAPTER 4: CONCLUSION
The TEA/tBoc treatment has successfully preserved the nanofibrous structure of
the chitosan membrane in water condition by removing the TFA salts and wrapping
the amine group. Adequate cell compatibilities and degradation rates have been
observed with these improved membranes. Also, increasing the thickness of the
membranes made a significant greater improvement of the mechanical strength of the
membranes.
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APPENDIX
Mechanical test - Suture pull out test
In clinical, membranes were also secured by suture other than tacks. The suture
pull out test was another way to evaluate the tearing strength of membranes. The
previous study of our group has tested the suture strength of Na2CO3 treated
membranes electrospun by 10 mL chitosan solution and a collagen membrane
(Biomend, Zimmer Dental).1 Based on the results of previous study, suture strength of
TEA/tBoc and Na2CO3 treated membranes electrospun by 30 mL chitosan solution
were tested here.
Method
Before the test, a single suture was made 5mm from the top edge and each sides
of the prepared membranes. The suture was a 70 cm general closure monofilament
polydioxanone (PDS II, Ethicon, Z-341) with taper ct-1 needle and 1(4.0 metric)
gauge. The sample with the suture through was clipped in the bottom claw of the
InstronTM model 4456 mechanical test frame. Mean-while, the un-knotted side of the
suture was affixed to the upper claw of the mechanical test frame (Fig. 1). The load
cell of the dry specimen suture pull out test was 50 N and the extension rate
was 1mm/min. Maximum load was recorded in Newton (N).
Result
Results of the suture pull out tests of different chitosan membranes and a
commercial collagen membrane are shown in Fig. 2. In this figure, results from a
previous study of a Na2CO3 treated membrane electrospun by 10 mL chitosan solution
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was included for reference. Compared to the degradable collagen membrane, both
types of chitosan membranes with increased thickness exhibited 65-72% lower suture
strengths. The torn edges for the TEA/tBoc and Na2CO3 treated membranes were
examined by SEM (Figure 3).
Discussion
The results of the suture pull out strength proved that the membranes with
increased thickness improved by 5X the tearing strength than the membrane
electrospun by 10 mL chitosan solution for the same post Na2CO3 electrospinning
treatment (Fig. 2). This indicates that increasing the thickness of the membrane
benefits the tearing strength of the membranes. There was no significant difference in
the suture strength between the TEA/tBoc treated and Na2CO3 treated membranes. By
observing the torn edge under the SEM, broken fibers could be observed at the torn
edge of the TEA/tBoc treated membrane (Fig. 3 A B), whereas only the flat fused
surface could be seen at the torn edge of the Na2CO3 treated membrane (Fig. 3 C).
The torn edge of the TEA/tBoc treated membrane proved that the tBoc process have
protected all the fibers including the inner layers. Comparing with the Biomend
crosslinked collage membrane, even chitosan membranes with increased thickness
were significantly less (65%-72%) in suture strength. Suture strength of TEA/tBoc
treated membrane still needs to be improved in the future.
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Fig. 1 The setup of suture pull out test. Load cell: 50N. Extension rate: 1mm/min.
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A
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C

Fig. 3 SEM graphs of the TEA/tBoc treated membrane tearing edge after suture pull
out test, A. 487X, B. 600X, and C. the Na2CO3 treated membrane tearing edge after
suture pull out test, 2500X.
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